Lal PathLabs can fortify its hold if suburban is integrated well

by

The funding of the acquisition through LPL’s existing cash reserves, while being an indicator of its strong financial position, would, on the other hand, largely wipe out its cash reserves.

Synopsis

Dr Lal PathLabs (LPL), India’s largest diagnostics player by revenue and presence, is slated to become bigger with the acquisition of Suburban Diagnostics, which has a sizable presence in western India. At the total deal value of Rs 1,150 crore, LPL valued Sequoia Capital-backed Suburban at nearly four times its FY21 revenue.

ET Intelligence Group: Dr Lal PathLabs (LPL), India’s largest diagnostics player by revenue and presence, is slated to become bigger with the acquisition of Suburban Diagnostics, which has a sizable presence in western India. At the total deal value of Rs 1,150 crore, LPL valued Sequoia Capital-backed Suburban at nearly four times its FY21 revenue.

The acquisition is going to provide LPL scale and penetration – it will help it add 44

BY

ET Bureau

3 mins read, Last Updated:

  • GIFT ARTICLE
  • FONT SIZE

    AbcSmall

    AbcMedium

    AbcLarge

  • SAVE
  • PRINT
  • COMMENT

Sign in to read the full article

You’ve got this Prime Story as a Free Gift

Already a Member?

THE GREAT DIWALI OFFER

GET FLAT 30% OFF

ON ET PRIME MEMBERSHIP

Get Offer

Why ?

  • 42031747

    Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors

  • 42031747

    Stock analysis. Market Research. Industry Trends on 4000+ Stocks

  • 42031747

    Clean experience with
    Minimal Ads

  • 42031747

    Comment & Engage with ET Prime community

  • 42031747

    Exclusive invites to Virtual Events with Industry Leaders

  • 42031747

    A trusted team of Journalists & Analysts who can best filter signal from noise



Source link

Leave a comment